Answers are grounded in this paper and cite their sources.
In mouse cells, loss of TSC1-2 keeps mTOR-S6K overactive and lowers IRS proteins, blunting insulin and IGF-1 signaling. Preclinical evidence.
No takes yet. Share an insight, caveat, or question.
Melania Mondini (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: